Louis VanderMolen

Louis VanderMolen, MD is a Clinical Professor of Medicine at the Keck School of Medicine, University of Southern California, and serves as Vice Chair of Clinical Oncology for the Orange County Program. His clinical expertise spans oncology and hematology, focusing on melanoma, renal cell carcinoma, and breast cancer.

• Education:
  • Medical Degree: Loyola University Stritch School of Medicine
  • Internal Medicine Internship/Residency: Baylor College of Medicine-Texas Medical Center
  • Hematology Fellowship: Baylor College of Medicine
  • Oncology Fellowship: National Cancer Institute-Clinical Oncology Program

Dr. VanderMolen’s research emphasizes immunotherapy, targeted therapies, and chemotherapy for metastatic cancers. Recent work includes PET/CT imaging for breast cancer and evaluating novel radiopharmaceuticals. His publications from 1985–2024 highlight clinical trials, biomarker studies, and treatment outcomes.

Key trends in his research include interleukin-2 therapy, autologous stem cell rescue, cancer vaccines, and radiopharmaceutical development. His studies often focus on improving survival in melanoma, renal cell carcinoma, and ovarian cancer.

• Scientific Awards:
  • Phi Beta Kappa Elected Member (1977)
  • Chief Resident, Internal Medicine at Baylor College of Medicine (1983–1984)
  • Physician of Excellence Award from Orange County Medical Association (2006–2013)

Dr. VanderMolen has contributed extensively to oncology literature, with a focus on clinical decision-making and therapeutic innovations. His collaborations span institutions including Baylor College of Medicine and the National Cancer Institute.